High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer
Tumors have exceptionally high demands for energy and anabolism because of their rapid growth. The de novo serine synthesis pathway initiated by phosphoglycerate dehydrogenase (PHGDH) has been recognized as a hallmark of metabolic adaption in carcinogenesis. The oncogenic role and prognostic value o...
Main Authors: | Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang, Xiaoyu Zhou, Jiahai Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523316301140 |
Similar Items
-
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor Prognosis
by: Boxi Zhang, et al.
Published: (2017-06-01) -
Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
by: Zhendong Wang, et al.
Published: (2021-07-01) -
Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer
by: Xiao-qin Jia, et al.
Published: (2016-06-01) -
GPR115 Contributes to Lung Adenocarcinoma Metastasis Associated With LAMC2 and Predicts a Poor Prognosis
by: Yingjing Wang, et al.
Published: (2020-11-01) -
Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
by: Kaiyuan Wang, et al.
Published: (2019-04-01)